| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Medicine, School of Medicine, Keio University, Tokyo, Japan; and
Department of Internal Medicine, Kitasato Institute Hospital, Tokyo, Japan
Although c-Jun NH2-terminal kinase (JNK) has been implicated in the pathogenesis of transplantation-induced ischemia/reperfusion (I/R) injury in various organs, its significance in lung transplantation has not been conclusively elucidated. We therefore attempted to measure the transitional changes in JNK and AP-1 activities in I/R-injured lungs. Subsequently, we assessed the effects of JNK inhibition by the three agents including SP600125 on the degree of lung injury assessed by means of various biological markers in bronchoalveolar lavage fluid and histological examination including detection of apoptosis. In addition, we evaluated the changes in p38, extracellular signal-regulated kinase, and NF-
B-DNA binding activity. I/R injury was established in the isolated rat lung preserved in modified Euro-Collins solution at 4°C for 4 h followed by reperfusion at 37°C for 3 h. We found that AP-1 was transiently activated during ischemia but showed sustained activation during reperfusion, leading to significant lung injury and apoptosis. The change in AP-1 was generally in parallel with that of JNK, which was activated in epithelial cells (bronchial and alveolar), alveolar macrophages, and smooth muscle cells (bronchial and vascular) on immunohistochemical examination. The change in NF-B qualitatively differed from that of AP-1. Protein leakage, release of lactate dehydrogenase and TNF-
into bronchoalveolar lavage fluid, and lung injury were improved, and apoptosis was suppressed by JNK inhibition. In conclusion, JNK plays a pivotal role in mediating lung injury caused by I/R. Therefore, inhibition of JNK activity has potential as an effective therapeutic strategy for preventing I/R injury during lung transplantation.
This article has been cited by other articles:
|
|
 |
|
  M. H. de Borst, J. Prakash, M. Sandovici, P. A. Klok, I. Hamming, R. J. Kok, G. Navis, and H. van Goor c-Jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 896 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lee, R. Reddy, L. Barsky, J. Scholes, H. Chen, W. Shi, and B. Driscoll Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L57 - L70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Nitta, A. H. Chu, and A. J. Wong Constitutive Activity of JNK2{alpha}2 Is Dependent on a Unique Mechanism of MAPK Activation J. Biol. Chem., December 12, 2008; 283(50): 34935 - 34945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mongan, Z. Tan, L. Chen, Z. Peng, M. Dietsch, B. Su, G. Leikauf, and Y. Xia Mitogen-activated Protein Kinase Kinase Kinase 1 Protects against Nickel-induced Acute Lung Injury Toxicol. Sci., August 1, 2008; 104(2): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Show, C. M. Hill, M. D. Anway, W. W. Wright, and B. R. Zirkin Phosphorylation of Mitogen-Activated Protein Kinase 8 (MAPK8) Is Associated With Germ Cell Apoptosis and Redistribution of the Bcl2-Modifying Factor (BMF) J Androl, May 1, 2008; 29(3): 338 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Marden, Y. Zhang, F. D. Oakley, W. Zhou, M. Luo, H. P. Jia, P. B. McCray Jr., M. Yaniv, J. B. Weitzman, and J. F. Engelhardt JunD Protects the Liver from Ischemia/Reperfusion Injury by Dampening AP-1 Transcriptional Activation J. Biol. Chem., March 14, 2008; 283(11): 6687 - 6695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Bennett c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur. Respir. J., September 1, 2006; 28(3): 651 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Arndt, S. K. Young, and G. S. Worthen Regulation of Lipopolysaccharide-Induced Lung Inflammation by Plasminogen Activator Inhibitor-1 through a JNK-Mediated Pathway J. Immunol., September 15, 2005; 175(6): 4049 - 4059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nakao, N. Murase, C. Ho, H. Toyokawa, T. R. Billiar, and S. Kanno Biliverdin Administration Prevents the Formation of Intimal Hyperplasia Induced by Vascular Injury Circulation, July 26, 2005; 112(4): 587 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Arndt, S. K. Young, J. G. Lieber, M. B. Fessler, J. A. Nick, and G. S. Worthen Inhibition of c-Jun N-Terminal Kinase Limits Lipopolysaccharide-induced Pulmonary Neutrophil Influx Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 978 - 986. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
